Today we’re sharing insight from guest blogger, Dr. Eric Bricker, Chief Medical Officer of Compass Professional Health Services. We hope you enjoy Dr. Bricker’s wisdom and perspective.
The February 28, 2017 issue of the Journal of the American Medical Association (JAMA) published an article by Dr. Michael Fischer and Dr. Jerry Avorn entitled, “Step Therapy—Clinical Algorithms, Legislation and Optimal Prescribing,” that explains the benefits of step therapy, an approach intended to control the costs and risks posed by prescription drugs.
Step therapy is a relatively new program offered by insurers and pharmacy benefits managers (PBMs) that requires patients to try lower cost or generic medications before they can ‘step up’ to a more expensive medication.